{"gene":"NEK3","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2004,"finding":"NEK3 physically interacts with Vav1 and Vav2 (identified by yeast two-hybrid and confirmed by co-immunoprecipitation) in a PRL-dependent manner. PRL stimulation induces NEK3 kinase activity and promotes Vav2/NEK3 co-association with the PRL receptor. NEK3 phosphorylates Vav2 on serine and tyrosine residues, and Rac1 activation requires both NEK3 and Vav2 and is blocked by a kinase-inactive NEK3 mutant.","method":"Yeast two-hybrid, co-immunoprecipitation, kinase activity assay, kinase-dead mutant overexpression, Rac1 activation assay","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, yeast two-hybrid, kinase-dead mutant, multiple orthogonal methods in one study replicated in subsequent work","pmids":["15618286"],"is_preprint":false},{"year":2007,"finding":"NEK3 is required for PRL-mediated cytoskeletal reorganization, Rac1 activation, cell migration, and invasion of breast cancer cells. PRL stimulation induces a NEK3–paxillin interaction and increases paxillin serine phosphorylation; siRNA-mediated NEK3 knockdown reduces paxillin phosphorylation and abolishes PRL-induced Rac1 activation.","method":"siRNA knockdown, overexpression in CHO transfectants, co-immunoprecipitation, Rac1 activation assay, migration/invasion assay, western blot","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function (siRNA), gain-of-function, Co-IP with paxillin, multiple readouts across two independent labs","pmids":["17297458"],"is_preprint":false},{"year":1999,"finding":"Murine NEK3 is a predominantly cytoplasmic serine/threonine kinase that shows no cell cycle-dependent variation in expression or kinase activity, and neither antibody microinjection nor overexpression of wild-type or catalytically inactive NEK3 affects cell cycle progression.","method":"Subcellular fractionation, antibody microinjection, overexpression, cell cycle staging, kinase assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by fractionation, functional assay by microinjection and overexpression, single lab","pmids":["10224116"],"is_preprint":false},{"year":2009,"finding":"NEK3 regulates microtubule acetylation in neurons. Phosphorylation at Thr475 in the C-terminal PEST domain acts as a regulatory switch: expression of phospho-defective (T475A) or PEST-truncated NEK3 in cultured neurons causes disturbed polarity and HDAC6-dependent deacetylation of microtubules in a kinase-dependent manner, whereas wild-type or phosphomimetic (T475D) NEK3 has no discernible effect.","method":"Site-directed mutagenesis (T475A/T475D), neuronal overexpression, immunofluorescence, HDAC6 pathway analysis","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-mutant analysis with functional readout, single lab, multiple mutant constructs","pmids":["19509051"],"is_preprint":false},{"year":2016,"finding":"ERK1/2 phosphorylates NEK3 at Thr-165 within the activation segment in response to PRL. A phospho-deficient NEK3-T165V mutant increases focal adhesion size, promotes zyxin-positive focal adhesion formation, induces actin stress fiber formation, and impairs breast cancer cell migration, establishing Thr-165 phosphorylation as a regulatory step controlling focal adhesion remodeling.","method":"Pharmacological ERK1/2 inhibition, siRNA knockdown of ERK1/2, phospho-deficient mutant expression (T165V), immunofluorescence of focal adhesions, migration assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-mutant plus pharmacological and siRNA approaches, single lab","pmids":["27489110"],"is_preprint":false},{"year":2018,"finding":"NEK3 phosphorylates SNAP29 at serine 105 (S105). This phosphorylation directs SNAP29 membrane association; a phospho-defective S105A mutant causes defective focal adhesion formation, impaired Golgi structure, and attenuated cellular recycling. Wild-type SNAP29 (but not S105A) partially rescues abnormal morphology in CEDNIK patient-derived fibroblasts.","method":"Phosphorylation assay, S105A phospho-deficient mutant expression, immunofluorescence, CEDNIK patient fibroblast rescue experiment","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-site mutagenesis with functional rescue, single lab, multiple readouts","pmids":["29454964"],"is_preprint":false},{"year":2020,"finding":"Biallelic loss-of-function NEK3 mutations in patients cause upregulation of SIRT2 and NNMT, leading to SIRT2-mediated α-tubulin deacetylation (detected by western blot and immunofluorescence) and downregulation of inner nuclear pore complex components NUP205, NUP188, and NUP155, associated with defective ciliary ultrastructure and abnormal cardiac left-right patterning.","method":"Whole-exome sequencing, NEK3 siRNA knockdown in RPE cells, western blot, immunofluorescence, transmission electron microscopy, transcriptome analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown with multiple orthogonal readouts (biochemical, TEM, transcriptomic), single lab, supported by patient genetics","pmids":["33230144"],"is_preprint":false},{"year":2026,"finding":"NEK3 protein levels regulate microtubule acetylation during mouse oocyte maturation; BPTMC-induced downregulation of NEK3 causes reduced microtubule acetylation and abnormal spindle assembly, impaired polar body extrusion, and defective embryonic development.","method":"In vitro oocyte maturation, NEK3 protein level analysis, immunofluorescence of spindle/microtubule acetylation, fertilization and embryo development assay","journal":"Environmental science & technology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlative knockdown in oocyte model, single lab, indirect inference of NEK3 mechanism from chemical exposure","pmids":["42235065"],"is_preprint":false}],"current_model":"NEK3 is a cytoplasmic NIMA-related serine/threonine kinase that, upon PRL receptor activation, is phosphorylated by ERK1/2 at Thr-165 to promote kinase activity; active NEK3 phosphorylates Vav2 to drive Rac1-dependent actin cytoskeletal reorganization and breast cancer cell migration, phosphorylates paxillin to remodel focal adhesions, and phosphorylates SNAP29 at Ser-105 to direct its membrane association and support Golgi integrity and cellular recycling; additionally, NEK3 activity (regulated by Thr-475 phosphorylation) suppresses HDAC6-mediated microtubule deacetylation in neurons, and NEK3 loss leads to SIRT2-dependent α-tubulin deacetylation and downregulation of inner nuclear pore complex components."},"narrative":{"mechanistic_narrative":"NEK3 is a predominantly cytoplasmic NIMA-related serine/threonine kinase that couples prolactin receptor (PRLR) signaling to actin cytoskeletal reorganization and cell motility, with no detectable role in cell cycle progression [PMID:10224116, PMID:15618286]. Upon prolactin (PRL) stimulation, NEK3 associates with the PRL receptor together with the guanine-nucleotide exchange factors Vav1/Vav2, phosphorylates Vav2 on serine and tyrosine residues, and drives Vav2-dependent Rac1 activation; this axis is abolished by a kinase-inactive NEK3 mutant [PMID:15618286]. Through this pathway NEK3 is required for PRL-induced cytoskeletal remodeling, paxillin phosphorylation, focal adhesion turnover, and breast cancer cell migration and invasion [PMID:17297458]. NEK3 catalytic output is gated by phosphorylation: ERK1/2 phosphorylates NEK3 at Thr-165 in the activation segment in response to PRL, and loss of this site enlarges focal adhesions, promotes stress fiber formation, and impairs migration [PMID:27489110]. NEK3 also phosphorylates SNAP29 at Ser-105 to direct SNAP29 membrane association and support Golgi integrity, focal adhesion formation, and cellular recycling [PMID:29454964]. A second regulatory phospho-switch at Thr-475 in the C-terminal PEST domain controls NEK3 activity toward microtubule acetylation in neurons, where loss of regulation drives HDAC6-dependent microtubule deacetylation and disturbed polarity [PMID:19509051]. Biallelic loss-of-function NEK3 mutations in patients cause SIRT2-mediated α-tubulin deacetylation and downregulation of inner nuclear pore components (NUP205, NUP188, NUP155), with defective ciliary ultrastructure and abnormal cardiac left-right patterning [PMID:33230144].","teleology":[{"year":1999,"claim":"Established the basic cellular identity of NEK3 as a constitutively active cytoplasmic kinase, ruling out the cell-cycle role expected of NIMA-related kinases and reframing where its function should be sought.","evidence":"Subcellular fractionation, antibody microinjection, overexpression, and cell cycle staging of murine NEK3","pmids":["10224116"],"confidence":"Medium","gaps":["No physiological substrate or upstream stimulus identified","Function in any signaling pathway undefined"]},{"year":2004,"claim":"Defined NEK3 as an effector of PRL receptor signaling by linking it to Vav2-dependent Rac1 activation, answering what pathway NEK3 acts within and identifying its first substrate.","evidence":"Yeast two-hybrid, reciprocal co-immunoprecipitation, kinase assays, kinase-dead mutant, and Rac1 activation assay in PRL-responsive cells","pmids":["15618286"],"confidence":"High","gaps":["Direct phosphorylation of Vav2 not mapped to specific residues","How PRLR triggers NEK3 activation not resolved"]},{"year":2007,"claim":"Connected NEK3 kinase activity to a concrete cellular phenotype, showing it is required for PRL-driven cytoskeletal remodeling, paxillin phosphorylation, and breast cancer cell migration/invasion.","evidence":"siRNA knockdown, overexpression, paxillin co-IP, and migration/invasion assays in breast cancer cells","pmids":["17297458"],"confidence":"High","gaps":["Whether paxillin is a direct NEK3 substrate not established","Mechanistic link between Rac1 and focal adhesion remodeling incomplete"]},{"year":2009,"claim":"Revealed a regulatory phospho-switch (Thr-475 in the PEST domain) and a new functional readout, showing NEK3 activity opposes HDAC6-dependent microtubule deacetylation and supports neuronal polarity.","evidence":"T475A/T475D site-directed mutagenesis with neuronal overexpression and HDAC6 pathway analysis","pmids":["19509051"],"confidence":"Medium","gaps":["Kinase responsible for Thr-475 phosphorylation unknown","Direct versus indirect control of HDAC6 not resolved"]},{"year":2016,"claim":"Identified the upstream activating event for NEK3, showing ERK1/2 phosphorylates Thr-165 in the activation segment to control focal adhesion remodeling and migration.","evidence":"ERK1/2 pharmacological inhibition and siRNA, T165V phospho-deficient mutant, focal adhesion immunofluorescence, and migration assays","pmids":["27489110"],"confidence":"Medium","gaps":["Direct ERK1/2 phosphorylation of NEK3 not shown in vitro","Relationship between Thr-165 and Thr-475 regulation untested"]},{"year":2018,"claim":"Expanded the NEK3 substrate repertoire to membrane trafficking, identifying SNAP29 Ser-105 as a phosphosite controlling Golgi integrity and recycling, with disease relevance in CEDNIK fibroblasts.","evidence":"Phosphorylation assay, S105A mutant expression, immunofluorescence, and CEDNIK patient fibroblast rescue","pmids":["29454964"],"confidence":"Medium","gaps":["How SNAP29 phosphorylation integrates with the Vav2/Rac1 axis unclear","In vivo relevance of the NEK3-SNAP29 link not established"]},{"year":2020,"claim":"Established NEK3 as a human disease gene whose loss converges on tubulin acetylation control via SIRT2 and on nuclear pore composition, linking it to ciliary defects and cardiac left-right patterning.","evidence":"Whole-exome sequencing of patients plus NEK3 siRNA in RPE cells with western blot, immunofluorescence, TEM, and transcriptome analysis","pmids":["33230144"],"confidence":"Medium","gaps":["Mechanism connecting NEK3 loss to SIRT2/NNMT upregulation unknown","Direct effect of NEK3 on nuclear pore components versus secondary consequence unresolved"]},{"year":2026,"claim":"Extended the NEK3-microtubule acetylation link to oocyte maturation, indicating NEK3 levels support spindle assembly and developmental competence.","evidence":"In vitro oocyte maturation under BPTMC exposure with NEK3 protein analysis, spindle/acetylation immunofluorescence, and embryo development assays","pmids":["42235065"],"confidence":"Low","gaps":["Correlative knockdown inferred from chemical exposure, not a direct NEK3 perturbation","Substrate or pathway mediating the acetylation effect not defined"]},{"year":null,"claim":"How NEK3's distinct substrate-specific roles (Vav2/Rac1 migration, SNAP29 trafficking, microtubule acetylation, nuclear pore regulation) are coordinated within a single cell, and which are direct versus indirect, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of NEK3 substrate recognition","Consensus phosphorylation motif undefined","Integration of Thr-165 and Thr-475 regulatory inputs untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,3,5]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,4,5]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4]}],"complexes":[],"partners":["VAV2","VAV1","PXN","SNAP29","MAPK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P51956","full_name":"Serine/threonine-protein kinase Nek3","aliases":["HSPK 36","Never in mitosis A-related kinase 3","NimA-related protein kinase 3"],"length_aa":506,"mass_kda":57.7,"function":"Protein kinase which influences neuronal morphogenesis and polarity through effects on microtubules. Regulates microtubule acetylation in neurons. Contributes to prolactin-mediated phosphorylation of PXN and VAV2. Implicated in prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells through mechanisms involving RAC1 activation and phosphorylation of PXN and VAV2","subcellular_location":"Cytoplasm; Cell projection, axon","url":"https://www.uniprot.org/uniprotkb/P51956/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NEK3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NEK3","total_profiled":1310},"omim":[{"mim_id":"609798","title":"NIMA-RELATED KINASE 9; NEK9","url":"https://www.omim.org/entry/609798"},{"mim_id":"604336","title":"TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY; TPTE","url":"https://www.omim.org/entry/604336"},{"mim_id":"604044","title":"NIMA-RELATED KINASE 3; NEK3","url":"https://www.omim.org/entry/604044"},{"mim_id":"604043","title":"NIMA-RELATED KINASE 2; NEK2","url":"https://www.omim.org/entry/604043"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Microtubules","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Cytokinetic bridge","reliability":"Additional"},{"location":"Mitotic spindle","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NEK3"},"hgnc":{"alias_symbol":["HSPK36","MGC29949"],"prev_symbol":[]},"alphafold":{"accession":"P51956","domains":[{"cath_id":"3.30.200.20","chopping":"1-80","consensus_level":"medium","plddt":87.9574,"start":1,"end":80},{"cath_id":"1.10.510.10","chopping":"84-287_471-490","consensus_level":"high","plddt":83.5176,"start":84,"end":490}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51956","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51956-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51956-F1-predicted_aligned_error_v6.png","plddt_mean":65.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NEK3","jax_strain_url":"https://www.jax.org/strain/search?query=NEK3"},"sequence":{"accession":"P51956","fasta_url":"https://rest.uniprot.org/uniprotkb/P51956.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51956/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51956"}},"corpus_meta":[{"pmid":"17297458","id":"PMC_17297458","title":"Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17297458","citation_count":68,"is_preprint":false},{"pmid":"15618286","id":"PMC_15618286","title":"Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor.","date":"2004","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15618286","citation_count":61,"is_preprint":false},{"pmid":"19509051","id":"PMC_19509051","title":"The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons.","date":"2009","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19509051","citation_count":59,"is_preprint":false},{"pmid":"10224116","id":"PMC_10224116","title":"Cloning and characterization of the murine Nek3 protein kinase, a novel member of the NIMA family of putative cell cycle regulators.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10224116","citation_count":31,"is_preprint":false},{"pmid":"10393247","id":"PMC_10393247","title":"NIMA-related kinases: isolation and characterization of murine nek3 and nek4 cDNAs, and chromosomal localization of nek1, nek2 and nek3.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10393247","citation_count":25,"is_preprint":false},{"pmid":"27489110","id":"PMC_27489110","title":"Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27489110","citation_count":23,"is_preprint":false},{"pmid":"33230144","id":"PMC_33230144","title":"Biallelic loss of function NEK3 mutations deacetylate α-tubulin and downregulate NUP205 that predispose individuals to cilia-related abnormal cardiac left-right patterning.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33230144","citation_count":16,"is_preprint":false},{"pmid":"12063396","id":"PMC_12063396","title":"Molecular cloning and characterization of the human NIMA-related protein kinase 3 gene (NEK3).","date":"2001","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12063396","citation_count":11,"is_preprint":false},{"pmid":"29454964","id":"PMC_29454964","title":"NEK3-mediated SNAP29 phosphorylation modulates its membrane association and SNARE fusion dependent processes.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29454964","citation_count":8,"is_preprint":false},{"pmid":"17118778","id":"PMC_17118778","title":"Is there any association between nek3 and cancers with frequent 13q14 deletion?","date":"2006","source":"Cancer investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17118778","citation_count":8,"is_preprint":false},{"pmid":"30667602","id":"PMC_30667602","title":"Identification of NEK3 and MOK as novel targets for lithium.","date":"2019","source":"Chemical biology & drug design","url":"https://pubmed.ncbi.nlm.nih.gov/30667602","citation_count":0,"is_preprint":false},{"pmid":"41483620","id":"PMC_41483620","title":"Multi-omics profiling reveals that targeting NEK3 synergizes with cuproptosis to promote M1 macrophage polarization in cervical cancer.","date":"2026","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41483620","citation_count":0,"is_preprint":false},{"pmid":"42235065","id":"PMC_42235065","title":"Bisphenol TMC Impaired Mouse Oocyte Maturation by Disrupting Spindle Assembly via NEK3-Mediated Microtubule Acetylation.","date":"2026","source":"Environmental science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/42235065","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7934,"output_tokens":2252,"usd":0.028791,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9277,"output_tokens":3061,"usd":0.061455,"stage2_stop_reason":"end_turn"},"total_usd":0.090246,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"NEK3 physically interacts with Vav1 and Vav2 (identified by yeast two-hybrid and confirmed by co-immunoprecipitation) in a PRL-dependent manner. PRL stimulation induces NEK3 kinase activity and promotes Vav2/NEK3 co-association with the PRL receptor. NEK3 phosphorylates Vav2 on serine and tyrosine residues, and Rac1 activation requires both NEK3 and Vav2 and is blocked by a kinase-inactive NEK3 mutant.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, kinase activity assay, kinase-dead mutant overexpression, Rac1 activation assay\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, yeast two-hybrid, kinase-dead mutant, multiple orthogonal methods in one study replicated in subsequent work\",\n      \"pmids\": [\"15618286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NEK3 is required for PRL-mediated cytoskeletal reorganization, Rac1 activation, cell migration, and invasion of breast cancer cells. PRL stimulation induces a NEK3–paxillin interaction and increases paxillin serine phosphorylation; siRNA-mediated NEK3 knockdown reduces paxillin phosphorylation and abolishes PRL-induced Rac1 activation.\",\n      \"method\": \"siRNA knockdown, overexpression in CHO transfectants, co-immunoprecipitation, Rac1 activation assay, migration/invasion assay, western blot\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function (siRNA), gain-of-function, Co-IP with paxillin, multiple readouts across two independent labs\",\n      \"pmids\": [\"17297458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Murine NEK3 is a predominantly cytoplasmic serine/threonine kinase that shows no cell cycle-dependent variation in expression or kinase activity, and neither antibody microinjection nor overexpression of wild-type or catalytically inactive NEK3 affects cell cycle progression.\",\n      \"method\": \"Subcellular fractionation, antibody microinjection, overexpression, cell cycle staging, kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by fractionation, functional assay by microinjection and overexpression, single lab\",\n      \"pmids\": [\"10224116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NEK3 regulates microtubule acetylation in neurons. Phosphorylation at Thr475 in the C-terminal PEST domain acts as a regulatory switch: expression of phospho-defective (T475A) or PEST-truncated NEK3 in cultured neurons causes disturbed polarity and HDAC6-dependent deacetylation of microtubules in a kinase-dependent manner, whereas wild-type or phosphomimetic (T475D) NEK3 has no discernible effect.\",\n      \"method\": \"Site-directed mutagenesis (T475A/T475D), neuronal overexpression, immunofluorescence, HDAC6 pathway analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-mutant analysis with functional readout, single lab, multiple mutant constructs\",\n      \"pmids\": [\"19509051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ERK1/2 phosphorylates NEK3 at Thr-165 within the activation segment in response to PRL. A phospho-deficient NEK3-T165V mutant increases focal adhesion size, promotes zyxin-positive focal adhesion formation, induces actin stress fiber formation, and impairs breast cancer cell migration, establishing Thr-165 phosphorylation as a regulatory step controlling focal adhesion remodeling.\",\n      \"method\": \"Pharmacological ERK1/2 inhibition, siRNA knockdown of ERK1/2, phospho-deficient mutant expression (T165V), immunofluorescence of focal adhesions, migration assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-mutant plus pharmacological and siRNA approaches, single lab\",\n      \"pmids\": [\"27489110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NEK3 phosphorylates SNAP29 at serine 105 (S105). This phosphorylation directs SNAP29 membrane association; a phospho-defective S105A mutant causes defective focal adhesion formation, impaired Golgi structure, and attenuated cellular recycling. Wild-type SNAP29 (but not S105A) partially rescues abnormal morphology in CEDNIK patient-derived fibroblasts.\",\n      \"method\": \"Phosphorylation assay, S105A phospho-deficient mutant expression, immunofluorescence, CEDNIK patient fibroblast rescue experiment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-site mutagenesis with functional rescue, single lab, multiple readouts\",\n      \"pmids\": [\"29454964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Biallelic loss-of-function NEK3 mutations in patients cause upregulation of SIRT2 and NNMT, leading to SIRT2-mediated α-tubulin deacetylation (detected by western blot and immunofluorescence) and downregulation of inner nuclear pore complex components NUP205, NUP188, and NUP155, associated with defective ciliary ultrastructure and abnormal cardiac left-right patterning.\",\n      \"method\": \"Whole-exome sequencing, NEK3 siRNA knockdown in RPE cells, western blot, immunofluorescence, transmission electron microscopy, transcriptome analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown with multiple orthogonal readouts (biochemical, TEM, transcriptomic), single lab, supported by patient genetics\",\n      \"pmids\": [\"33230144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"NEK3 protein levels regulate microtubule acetylation during mouse oocyte maturation; BPTMC-induced downregulation of NEK3 causes reduced microtubule acetylation and abnormal spindle assembly, impaired polar body extrusion, and defective embryonic development.\",\n      \"method\": \"In vitro oocyte maturation, NEK3 protein level analysis, immunofluorescence of spindle/microtubule acetylation, fertilization and embryo development assay\",\n      \"journal\": \"Environmental science & technology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlative knockdown in oocyte model, single lab, indirect inference of NEK3 mechanism from chemical exposure\",\n      \"pmids\": [\"42235065\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NEK3 is a cytoplasmic NIMA-related serine/threonine kinase that, upon PRL receptor activation, is phosphorylated by ERK1/2 at Thr-165 to promote kinase activity; active NEK3 phosphorylates Vav2 to drive Rac1-dependent actin cytoskeletal reorganization and breast cancer cell migration, phosphorylates paxillin to remodel focal adhesions, and phosphorylates SNAP29 at Ser-105 to direct its membrane association and support Golgi integrity and cellular recycling; additionally, NEK3 activity (regulated by Thr-475 phosphorylation) suppresses HDAC6-mediated microtubule deacetylation in neurons, and NEK3 loss leads to SIRT2-dependent α-tubulin deacetylation and downregulation of inner nuclear pore complex components.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NEK3 is a predominantly cytoplasmic NIMA-related serine/threonine kinase that couples prolactin receptor (PRLR) signaling to actin cytoskeletal reorganization and cell motility, with no detectable role in cell cycle progression [#2, #0]. Upon prolactin (PRL) stimulation, NEK3 associates with the PRL receptor together with the guanine-nucleotide exchange factors Vav1/Vav2, phosphorylates Vav2 on serine and tyrosine residues, and drives Vav2-dependent Rac1 activation; this axis is abolished by a kinase-inactive NEK3 mutant [#0]. Through this pathway NEK3 is required for PRL-induced cytoskeletal remodeling, paxillin phosphorylation, focal adhesion turnover, and breast cancer cell migration and invasion [#1]. NEK3 catalytic output is gated by phosphorylation: ERK1/2 phosphorylates NEK3 at Thr-165 in the activation segment in response to PRL, and loss of this site enlarges focal adhesions, promotes stress fiber formation, and impairs migration [#4]. NEK3 also phosphorylates SNAP29 at Ser-105 to direct SNAP29 membrane association and support Golgi integrity, focal adhesion formation, and cellular recycling [#5]. A second regulatory phospho-switch at Thr-475 in the C-terminal PEST domain controls NEK3 activity toward microtubule acetylation in neurons, where loss of regulation drives HDAC6-dependent microtubule deacetylation and disturbed polarity [#3]. Biallelic loss-of-function NEK3 mutations in patients cause SIRT2-mediated \\u03b1-tubulin deacetylation and downregulation of inner nuclear pore components (NUP205, NUP188, NUP155), with defective ciliary ultrastructure and abnormal cardiac left-right patterning [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the basic cellular identity of NEK3 as a constitutively active cytoplasmic kinase, ruling out the cell-cycle role expected of NIMA-related kinases and reframing where its function should be sought.\",\n      \"evidence\": \"Subcellular fractionation, antibody microinjection, overexpression, and cell cycle staging of murine NEK3\",\n      \"pmids\": [\"10224116\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No physiological substrate or upstream stimulus identified\", \"Function in any signaling pathway undefined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined NEK3 as an effector of PRL receptor signaling by linking it to Vav2-dependent Rac1 activation, answering what pathway NEK3 acts within and identifying its first substrate.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-immunoprecipitation, kinase assays, kinase-dead mutant, and Rac1 activation assay in PRL-responsive cells\",\n      \"pmids\": [\"15618286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation of Vav2 not mapped to specific residues\", \"How PRLR triggers NEK3 activation not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected NEK3 kinase activity to a concrete cellular phenotype, showing it is required for PRL-driven cytoskeletal remodeling, paxillin phosphorylation, and breast cancer cell migration/invasion.\",\n      \"evidence\": \"siRNA knockdown, overexpression, paxillin co-IP, and migration/invasion assays in breast cancer cells\",\n      \"pmids\": [\"17297458\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether paxillin is a direct NEK3 substrate not established\", \"Mechanistic link between Rac1 and focal adhesion remodeling incomplete\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed a regulatory phospho-switch (Thr-475 in the PEST domain) and a new functional readout, showing NEK3 activity opposes HDAC6-dependent microtubule deacetylation and supports neuronal polarity.\",\n      \"evidence\": \"T475A/T475D site-directed mutagenesis with neuronal overexpression and HDAC6 pathway analysis\",\n      \"pmids\": [\"19509051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase responsible for Thr-475 phosphorylation unknown\", \"Direct versus indirect control of HDAC6 not resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified the upstream activating event for NEK3, showing ERK1/2 phosphorylates Thr-165 in the activation segment to control focal adhesion remodeling and migration.\",\n      \"evidence\": \"ERK1/2 pharmacological inhibition and siRNA, T165V phospho-deficient mutant, focal adhesion immunofluorescence, and migration assays\",\n      \"pmids\": [\"27489110\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ERK1/2 phosphorylation of NEK3 not shown in vitro\", \"Relationship between Thr-165 and Thr-475 regulation untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Expanded the NEK3 substrate repertoire to membrane trafficking, identifying SNAP29 Ser-105 as a phosphosite controlling Golgi integrity and recycling, with disease relevance in CEDNIK fibroblasts.\",\n      \"evidence\": \"Phosphorylation assay, S105A mutant expression, immunofluorescence, and CEDNIK patient fibroblast rescue\",\n      \"pmids\": [\"29454964\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How SNAP29 phosphorylation integrates with the Vav2/Rac1 axis unclear\", \"In vivo relevance of the NEK3-SNAP29 link not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established NEK3 as a human disease gene whose loss converges on tubulin acetylation control via SIRT2 and on nuclear pore composition, linking it to ciliary defects and cardiac left-right patterning.\",\n      \"evidence\": \"Whole-exome sequencing of patients plus NEK3 siRNA in RPE cells with western blot, immunofluorescence, TEM, and transcriptome analysis\",\n      \"pmids\": [\"33230144\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting NEK3 loss to SIRT2/NNMT upregulation unknown\", \"Direct effect of NEK3 on nuclear pore components versus secondary consequence unresolved\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Extended the NEK3-microtubule acetylation link to oocyte maturation, indicating NEK3 levels support spindle assembly and developmental competence.\",\n      \"evidence\": \"In vitro oocyte maturation under BPTMC exposure with NEK3 protein analysis, spindle/acetylation immunofluorescence, and embryo development assays\",\n      \"pmids\": [\"42235065\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Correlative knockdown inferred from chemical exposure, not a direct NEK3 perturbation\", \"Substrate or pathway mediating the acetylation effect not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NEK3's distinct substrate-specific roles (Vav2/Rac1 migration, SNAP29 trafficking, microtubule acetylation, nuclear pore regulation) are coordinated within a single cell, and which are direct versus indirect, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of NEK3 substrate recognition\", \"Consensus phosphorylation motif undefined\", \"Integration of Thr-165 and Thr-475 regulatory inputs untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 3, 5]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"VAV2\", \"VAV1\", \"PXN\", \"SNAP29\", \"MAPK1\"]\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}